{"id":"https://openalex.org/W2983176764","doi":"https://doi.org/10.1182/blood-2019-131145","title":"Malignant T-Cells and Normal Intratumoral T-Cells Have Similar Expression of Immune Checkpoint Molecules in Angioimmunoblastic T-Cell Lymphoma","display_name":"Malignant T-Cells and Normal Intratumoral T-Cells Have Similar Expression of Immune Checkpoint Molecules in Angioimmunoblastic T-Cell Lymphoma","publication_year":2019,"publication_date":"2019-11-13","ids":{"openalex":"https://openalex.org/W2983176764","doi":"https://doi.org/10.1182/blood-2019-131145","mag":"2983176764"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2019-131145","doi":"https://doi.org/10.1182/blood-2019-131145","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2019-131145","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017156539","display_name":"Joshua C. Pritchett","orcid":"https://orcid.org/0000-0001-6139-5526","observed_orcids":["https://orcid.org/0000-0001-6139-5526"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joshua C Pritchett","raw_affiliation_strings":["Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063296982","display_name":"Zhi-Zhang Yang","orcid":"https://orcid.org/0000-0002-1468-2300","observed_orcids":["https://orcid.org/0000-0002-1468-2300"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zhi-Zhang Yang","raw_affiliation_strings":["Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100439174","display_name":"Hyo-Jin Kim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hyojin Kim","raw_affiliation_strings":["Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037629427","display_name":"Jose Caetano Villasboas","orcid":"https://orcid.org/0000-0002-2907-0809","observed_orcids":["https://orcid.org/0000-0002-2907-0809"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jose C Villasboas","raw_affiliation_strings":["Division of Hematology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090406453","display_name":"Andrew L. Feldman","orcid":"https://orcid.org/0000-0001-5009-4808","observed_orcids":["https://orcid.org/0000-0001-5009-4808"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew L. Feldman","raw_affiliation_strings":["Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076621021","display_name":"James R. Cerhan","orcid":"https://orcid.org/0000-0002-7482-178X","observed_orcids":["https://orcid.org/0000-0002-7482-178X"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James R. Cerhan","raw_affiliation_strings":["Division of Hematology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5059729547","display_name":"Stephen Maxted Ansell","orcid":"https://orcid.org/0000-0003-1244-6758","observed_orcids":["https://orcid.org/0000-0003-1244-6758"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen M Ansell","raw_affiliation_strings":["Division of Hematology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1330342723"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"134","issue":"Supplement_1","first_page":"1517","last_page":"1517"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9839000105857849,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9839000105857849,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.006300000008195639,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.005900000222027302,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/angioimmunoblastic-t-cell-lymphoma","display_name":"angioimmunoblastic T-cell lymphoma","score":0.9990000128746033},{"id":"https://openalex.org/keywords/immune-checkpoint-proteins","display_name":"immune checkpoint molecules","score":0.8920000195503235},{"id":"https://openalex.org/keywords/pd-1","display_name":"PD-1","score":0.7630000114440918},{"id":"https://openalex.org/keywords/inducible-t-cell-costimulator","display_name":"ICOS","score":0.9769999980926514},{"id":"https://openalex.org/keywords/tigit","display_name":"TIGIT","score":0.8659999966621399},{"id":"https://openalex.org/keywords/cd27","display_name":"CD27","score":0.8629999756813049},{"id":"https://openalex.org/keywords/tim-3","display_name":"TIM-3","score":0.7789999842643738},{"id":"https://openalex.org/keywords/lag-3","display_name":"LAG-3","score":0.9890000224113464},{"id":"https://openalex.org/keywords/ctla-4","display_name":"CTLA-4","score":0.9950000047683716},{"id":"https://openalex.org/keywords/t-follicular-helper-cells","display_name":"T follicular helper cells","score":0.8550000190734863},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.8560000061988831},{"id":"https://openalex.org/keywords/peripheral-blood-biomarkers","display_name":"peripheral blood biomarkers","score":0.5699999928474426},{"id":"https://openalex.org/keywords/cutaneous-t-cell-lymphoma","display_name":"cutaneous T-cell lymphoma","score":0.75},{"id":"https://openalex.org/keywords/peripheral-t-cell-lymphoma","display_name":"peripheral T-cell lymphoma","score":0.8970000147819519}],"concepts":[{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5666886568069458},{"id":"https://openalex.org/C2776365654","wikidata":"https://www.wikidata.org/wiki/Q4763257","display_name":"Angioimmunoblastic T-cell lymphoma","level":4,"score":0.5590806007385254},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.5348628163337708},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.46918582916259766},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4649917185306549},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4525356888771057},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.44662389159202576},{"id":"https://openalex.org/C2779118045","wikidata":"https://www.wikidata.org/wiki/Q21114021","display_name":"TIGIT","level":4,"score":0.4263162314891815},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3788739740848541},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.36784714460372925},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3564431667327881},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3430403470993042},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.25156599283218384}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2019-131145","doi":"https://doi.org/10.1182/blood-2019-131145","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2019-131145","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.699999988079071,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2898485571","https://openalex.org/W4313385114","https://openalex.org/W2592785733","https://openalex.org/W4254198294","https://openalex.org/W3204309362","https://openalex.org/W3211450793","https://openalex.org/W2899557518","https://openalex.org/W4220675202","https://openalex.org/W3197815049","https://openalex.org/W2915463460"],"abstract_inverted_index":{"BACKGROUND:":[0],"Angioimmunoblastic":[1],"T":[2,38,372],"cell":[3,35,42,332],"lymphoma":[4],"(AITL)":[5],"has":[6,36],"a":[7,12,37,103,142,166,304,366,471,512,519,548],"unique":[8,472],"histological":[9],"phenotype":[10,43,108,473,522],"with":[11,44,78,351,486,554],"relatively":[13,340],"small":[14,315],"number":[15],"of":[16,23,47,59,70,109,149,157,168,232,245,256,268,273,283,291,306,317,357,370,391,418,483,515,526,550,566,575,578,595],"malignant":[17,34,90,113,250,276,344,492,537],"T-cells":[18,91,94,111,114,217,251,293,319,381,467,493,517,527],"and":[19,31,53,92,112,135,154,162,187,203,213,241,247,270,286,301,303,312,323,365,404,505,509,536,569],"an":[20,335,592],"extensive":[21],"infiltrate":[22],"normal":[24,93,110,178,292,318,330,371,423,450,516,535],"cells":[25,30,156,264,308],"including":[26,51,210,299,507],"T-cells,":[27],"B-cells,":[28],"NK":[29],"FDCs.":[32,379],"The":[33],"follicular":[39],"helper":[40],"(Tfh)":[41],"increased":[45,413,445,562],"expression":[46,231,282],"immune":[48,62,124,185,258,296,392,500],"checkpoint":[49,63,125,259,297,393,402],"molecules":[50,126,260,298,394,502],"PD-1":[52,99,240,300,410,504,555,559],"ICOS.":[54,242,313],"With":[55],"the":[56,107,116,128,329,343,388,407,415,542,564,572],"routine":[57],"use":[58,482],"antibodies":[60,580],"targeting":[61],"molecules,":[64],"clinical":[65,576],"results":[66],"in":[67,95,127,218,395,406,414,431,438,446,456,463,468,528,547,563,581],"limited":[68],"numbers":[69],"AITL":[71,96,173,219,419,432,447,457,469,551,567],"patients":[72,81,174,552,568],"have":[73,327,470,518],"thus":[74],"far":[75],"been":[76],"mixed":[77],"some":[79,84],"responding":[80],"but":[82,275,346,374],"also":[83,120,294,309],"who":[85],"rapidly":[86],"progress.":[87],"Because":[88],"both":[89,534],"may":[97,540,570],"be":[98,223,360,478],"positive,":[100],"we":[101,398],"conducted":[102],"study":[104],"to":[105,152,176,342,387,422,449,477,496],"compare":[106],"within":[115,165],"tumor":[117],"microenvironment.":[118],"We":[119,140],"evaluated":[121],"whether":[122],"soluble":[123,401,441,558],"peripheral":[129,196,416],"blood":[130,197,417],"differed":[131],"between":[132],"AITLs,":[133,200],"controls,":[134,202],"other":[136,257],"PTCL":[137,208],"subgroups.":[138],"METHODS:":[139],"designed":[141],"novel":[143],"CyTOF":[144,230,353,488],"antibody":[145],"(Ab)":[146],"panel":[147],"comprised":[148],"37":[150],"markers":[151],"identify":[153],"characterize":[155],"T,":[158],"B,":[159],"NK,":[160],"macrophage":[161],"FDC":[163],"lineages":[164],"cohort":[167],"biopsy":[169],"specimens":[170,220],"from":[171,198,207],"6":[172,177],"compared":[175,421,448],"controls":[179,424,451],"(2":[180],"LN,":[181],"4":[182],"tonsil).":[183],"Soluble":[184,409],"receptors":[186,403],"ligands":[188,405],"were":[189,279,494],"then":[190,399],"measured":[191,400],"by":[192,225],"multiplex":[193],"ELISA":[194],"on":[195,229,249,362,376,591],"8":[199],"5":[201],"32":[204],"additional":[205,499],"samples":[206],"subtypes":[209],"PTCL-NOS,":[211],"ALCL":[212],"CTCL.":[214],"RESULTS:":[215],"Malignant":[216,263,380,466],"could":[221,359],"clearly":[222],"identified":[224,480],"viSNE":[226,349,484],"mapping":[227,350,485],"based":[228],"CD4,":[233],"CD5,":[234],"BCL6,":[235],"CD10":[236],"(variable),":[237,239],"CXCR5":[238],"Aberrant":[243],"loss":[244],"CD3":[246],"CD7":[248],"was":[252,261,338,411,443,475],"commonly":[253],"seen.":[254],"Expression":[255,356],"assessed.":[262],"expressed":[265,295,310,320],"high":[266],"levels":[267,272],"TIGIT":[269,311,508],"moderate":[271],"CD27,":[274,302],"T-cell":[277],"populations":[278,369],"negative":[280],"for":[281],"TIM3,":[284,321],"LAG3,":[285,322],"CTLA-4.":[287,324],"A":[288,314],"substantial":[289,513],"proportion":[290],"subset":[305,514,549],"these":[307],"minority":[316],"As":[325],"others":[326],"described,":[328],"Tfh":[331],"population":[333],"had":[334],"immunophenotype":[336],"that":[337,524],"otherwise":[339],"similar":[341,521],"population,":[345],"distinguishable":[347],"via":[348],"our":[352,487],"Ab":[354,489],"panel.":[355,490],"PD-L1":[358,442],"detected":[361],"NK-cells,":[363],"macrophages,":[364],"few":[367],"select":[368],"cells,":[373],"not":[375,383],"B-cells":[377],"or":[378,597],"did":[382],"express":[384,498],"PD-L1.":[385],"Due":[386],"potential":[389],"importance":[390],"this":[396,529],"disease,":[397],"serum.":[408],"significantly":[412,444,561],"when":[420],"(average":[425],"2637":[426],"pg/mL":[427],"(SE":[428,435,453,460],"=":[429,436,454,461],"512.1)":[430],"vs":[433,458],"57.87":[434],"16.88)":[437],"controls).":[439,464],"Similarly,":[440],"(13.8":[452],"10.5)":[455],"0.94":[459],"0.25)":[462],"CONCLUSIONS:":[465],"which":[474],"able":[476],"reliably":[479],"through":[481],"Furthermore,":[491,557],"found":[495],"consistently":[497],"regulatory":[501],"beyond":[503],"ICOS,":[506],"CD27.":[510],"However,":[511],"very":[520],"suggesting":[523],"activation":[525],"disease":[530,544],"will":[531],"likely":[532],"stimulate":[533],"T-cells.":[538],"This":[539],"explain":[541,571],"rapid":[543],"progression":[545],"seen":[546],"treated":[553],"blockade.":[556],"is":[560],"serum":[565],"overall":[573],"lack":[574],"efficacy":[577],"anti-PD-1":[579],"treating":[582],"AITL.":[583],"Disclosures":[584],"Cerhan:":[585],"NanoString:":[586],"Research":[587,601,605,609,612,616,619,623,627,630,634,637,640,643,647,651,655,659,663,666,669,676,679,682,685,688,691,699,702,710,713,720,724,728,731,735,743,746,750,754,758,761,764,767,771,774,777,781,785,792,796,804,808,811,822,826],"Funding;":[588,606,610,613,617,620,624,628,631,635,638,641,644,648,652,656,660,664,667,670,677,680,683,686,689,692,700,703,711,714,721,725,729,732,736,744,747,751,755,759,762,765,768,772,775,778,782,786,793,797,805,809,812,823],"Janssen:":[589],"Membership":[590],"entity's":[593],"Board":[594],"Directors":[596],"advisory":[598],"committees;":[599],"Celgene:":[600],"Funding.":[602,827],"Ansell:LAM":[603],"Therapeutics:":[604,633,658,662,698,749,753,770,825],"Seattle":[607,614,649,708,733,741,756,802,806],"Genetics:":[608,615,650,709,734,742,757,803,807],"Trillium:":[611,629,636,639,642,712,776,791,810],"Affimed:":[618,668,678,687,690,701,719,760,773],"Bristol-Myers":[621,625,645,653,722,726,779,783,794],"Squibb:":[622,626,646,654,723,727,780,784,795],"LAM":[632,657,661,697,748,752,769,824],"Regeneron:":[665,675,681,684,730,745,763,766,821],"Mayo":[671,693,704,715,737,787,798,813,817],"Clinic":[672,694,705,716,738,788,799,814,818],"Rochester:":[673,695,706,717,739,789,800,815,819],"Employment;":[674,696,707,718,740,790,801,816,820]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2025-10-10T00:00:00"}